BSE filing, BSE: 542678. Summary written from the filing by ALFA Finder's alert engine.
Cian Healthcare Ltd: key numbers
- Share price
- ₹32.20
- Market cap
- ₹80.50 Cr
- Revenue (annual)
- ₹28.30 Cr
- Net profit (annual)
- ₹-23.29 Cr
- Promoter holding
- 95.00%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cian Healthcare Ltd
All →Cian Healthcare Merger & Restructuring
Cian Healthcare disposed of its Dr. Smiths Biotech subsidiary under an NCLT-approved resolution plan. Its equity was cancelled with nil consideration receivable.
Cian Healthcare Insolvency Petition
Cian Healthcare's subsidiary Dr. Smiths Biotech ceased to be a subsidiary after NCLT approved Ananta Medicare's resolution plan. Equity was extinguished with no consideration received.
Cian Healthcare Other Announcement
Cian Healthcare filed its quarterly shareholding pattern. The company disclosed it is working to restore public shareholding levels following an NCLT-approved resolution plan.
Cian Healthcare Management Change
Cian Healthcare Limited has appointed M/s. Rasool Singhal & Co. as the new Statutory Auditor for a term of 60 months.
Cian Healthcare Annual General Meeting
Cian Healthcare Ltd held its 23rd AGM on September 29, 2026, approving financial statements, director re-appointment, auditor appointment, and the 2026 Employee Stock Option Scheme.
Cian Healthcare Annual Report
Cian Healthcare Limited has filed its Annual Report for the financial year ended March 31, 2026, and the Notice of its 23rd Annual General Meeting.
Other employee stock options announcements
All →IIFL Capital Services Employee Stock Options
IIFL Capital Services granted 29,713 ESOPs and allotted 180,499 shares on exercise under its 2018 ESOS scheme. The equity base rose to 315,532,512 shares of ₹2 each.
Brigade Enterprises Employee Stock Options
Brigade Enterprises approved allotment of 39,094 ESOP shares and granted 1,484,344 options under its new 2026 ESOP scheme. Paid-up capital rose by Rs. 39.1 lakh due to the allotment.
SBI Cards and Payment Services Employee Stock Options
SBI Cards allotted 5,560 equity shares on exercise of options under its ESOP Plan 2019 and 2023. Paid-up capital rose to Rs.9,516.43 Crore post-allotment.
Restaurant Brands Asia Employee Stock Options
Restaurant Brands Asia allotted 9,259 equity shares under its ESOP Scheme 2015. Paid-up capital rose to 71,22,27,588 shares.
RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.